In 2018, we achieved reported net sales growth of 9.3% and maintained our capital allocation strategy that prioritizes acquisitions, dividends, and share repurchases. Our capital allocation strategy included investing $2,451 in acquisitions, which reflects our commitment to enhancing our technology capabilities and operational efficiency. The acquisition of K2M Group Holdings, Inc. and Entellus Medical, Inc. illustrates our focus on integrating advanced technologies to support our business processes and improve customer relationships. Research, development, and engineering expenses represented 6.3% of net sales, indicating our investment in new technologies and product development to meet evolving business needs. The adoption of accounting standards update 2014-09 (ASC 606) has impacted our revenue recognition, necessitating adjustments in our financial reporting to reflect the true performance of our operations. Our effective management of cash flow from operations, which totaled $2,610 million, demonstrates our ability to mobilize resources effectively to support ongoing operations and strategic investments. We believe our financial condition remains strong, supported by our ability to generate substantial cash from operations and access capital markets at competitive rates, which is crucial for funding our technology investments and acquisitions. Our operational flexibility is enhanced by a robust cash management strategy that considers liquidity management and economic factors. The integration of acquired companies is essential for leveraging their technological capabilities and enhancing our overall operational effectiveness. We continue to focus on improving our internal processes and optimizing our business strategies to respond to market dynamics and consumer demands effectively. Our commitment to innovation is reflected in our strategic resource allocation towards research and development, which is vital for maintaining a competitive advantage in the medical technology industry. We recognize the importance of IT capabilities in supporting our business transformation initiatives and enhancing our organizational capabilities. The strategic decisions made regarding acquisitions and investments in technology resources are aimed at improving our market responsiveness and operational efficiency. Our focus on building a strong technology infrastructure is critical for achieving long-term performance gains and sustaining our competitive positioning in the market. We are committed to ensuring that our IT governance aligns with our organizational goals and supports our business strategy, thereby facilitating effective decision-making and resource management. The challenges posed by regulatory and market changes necessitate a proactive approach to managing our technology portfolio and ensuring compliance with evolving standards. Our ability to adapt to these changes while leveraging our IT capabilities will be instrumental in driving future growth and enhancing our overall business performance.